Discovery & Development

Aptar Pharma announces the re-launch of its Bag-on-Valve (BOV) activities in its Radolfzell manufacturing site

How can we overcome bioavailability challenges in our increasingly complex drug pipeline?

A new model for cocrystal formation could be a powerful tool for formulation scientists – no crystal structures required, it’s all about the surface contacts.

Making medicines for pediatrics adds a whole new dimension to the challenges of formulation and drug delivery

Electrochemical reaction cells are finding new applications in the pharma R&D lab that could offer big time and cost savings.

The days of “low-hanging fruit” in drug discovery are a thing of the past.

Could medicines be made more effective with better timing?

If I knew six years ago just how much of my time EXCiPACT would take up, would I have even started?

New NIH policies aim to correct the sex bias in preclinical research.

Our understanding of the differences in male and female biology is constantly growing – but can we translate that knowledge into better healthcare for all?